Form 4 for MOH MOLINA HEALTHCARE, INC.
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001179929-24-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-14 | 2024-02-12 | MOH | Keim Mark Lowell | CFO | S - Sale | $386.56 | -15.0K | 36.5K | -29% | -$5.80M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | S | D | 1,264 | $388.61 | 50,267 | D | — | — | (F1) Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-12 | S | D | 4,251 | $387.94 | 46,016 | D | — | — | (F2) Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-02-12 | S | D | 4,351 | $387.00 | 41,665 | D | — | — | (F3) Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-02-12 | S | D | 1,203 | $385.80 | 40,462 | D | — | — | (F4) Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-02-12 | S | D | 1,815 | $384.58 | 38,647 | D | — | — | (F5) Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2024-02-12 | S | D | 2,116 | $383.82 | 36,531 | D | — | — | (F6) Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. (F7) Amount of shares beneficially owned reflects an additional 102 shares arising from a calculation error in connection with the payment of withholding taxes related to a vesting event on January 10, 2020. |